<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.harmreductionjournal.com/feeds/latestarticles/journal?quantity=&amp;format=rss&amp;version=">
        <title>Harm Reduction Journal - Latest Articles</title>
        <link>http://www.harmreductionjournal.com</link>
        <description>The latest research articles published by Harm Reduction Journal</description>
        <dc:date>2013-05-07T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.harmreductionjournal.com/content/10/1/8" />
                                <rdf:li rdf:resource="http://www.harmreductionjournal.com/content/10/1/7" />
                                <rdf:li rdf:resource="http://www.harmreductionjournal.com/content/10/1/6" />
                                <rdf:li rdf:resource="http://www.harmreductionjournal.com/content/10/1/5" />
                                <rdf:li rdf:resource="http://www.harmreductionjournal.com/content/10/1/4" />
                                <rdf:li rdf:resource="http://www.harmreductionjournal.com/content/10/1/3" />
                                <rdf:li rdf:resource="http://www.harmreductionjournal.com/content/10/1/2" />
                                <rdf:li rdf:resource="http://www.harmreductionjournal.com/content/10/1/1" />
                                <rdf:li rdf:resource="http://www.harmreductionjournal.com/content/9/1/40" />
                                <rdf:li rdf:resource="http://www.harmreductionjournal.com/content/9/1/39" />
                            </rdf:Seq>
        </items>
                 <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.harmreductionjournal.com/content/10/1/8">
        <title>Ability to access community-based needle-syringe programs and injecting behaviors among drug users: a cross-sectional study in Hunan Province, China</title>
        <description>Background:
Needle-syringe exchange programs (NSPs) have been substantially rolled-out in China since 2002. Limited studies reported effectiveness of NSPs in a Chinese setting. This study aimed to assess the association between accessibility to NSPs and drug-use risk behaviors of IDUs by investigating primary (self-reported) data of IDUs recruited from NSP sites, community settings and mandatory detoxification centers (MDCs) in Hunan province, China.
Methods:
A cross-sectional survey was conducted in Hunan province in 2010. IDU recruits participated in a face-to-face interview to provide information related to their ability to access NSPs, demographic characteristics, and injecting behaviors in the past 30 days.
Results:
Of the total 402 participants, 35%, 14% and 51% participants indicated low, medium and high ability to access NSPs in the past 30 days, respectively. A significantly higher proportion of IDUs (77.3%) from the high-access group reported &lt;=2 injecting episodes per day compared with medium- (46.3%) and low-access (58.8%) groups. Only 29.0% of high-access IDUs re-used syringes before disposal in the past 30 days, significantly lower than those in the medium- (43.1%) and low-access (41.3%) groups. Reported levels of needle/syringe sharing decreased significantly as the ability to access NSPs increased (16.3%, 12.7% and 2.5% in the low, medium and high access groups, respectively). Ninety percent of IDUs recruited from MDCs had low ability to access NSPs.
Conclusions:
Increased NSP accessibility is associated with decreased levels of injecting frequency, repetitive use and sharing of injecting equipment among Chinese IDUs. Mandatory detention of IDUs remains as a major barrier for IDUs to access NSPs in China.</description>
        <link>http://www.harmreductionjournal.com/content/10/1/8</link>
                <dc:creator>Lei Zhang</dc:creator>
                <dc:creator>Xi Chen</dc:creator>
                <dc:creator>Jun Zheng</dc:creator>
                <dc:creator>Junshi Zhao</dc:creator>
                <dc:creator>Jun Jing</dc:creator>
                <dc:creator>Jun Zhang</dc:creator>
                <dc:creator>Eric Chow</dc:creator>
                <dc:creator>David Wilson</dc:creator>
                <dc:source>Harm Reduction Journal 2013, null:8</dc:source>
        <dc:date>2013-05-07T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-7517-10-8</dc:identifier>
                                <prism:require>/content/figures/1477-7517-10-8-toc.gif</prism:require>
                <prism:publicationName>Harm Reduction Journal</prism:publicationName>
        <prism:issn>1477-7517</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>8</prism:startingPage>
        <prism:publicationDate>2013-05-07T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.harmreductionjournal.com/content/10/1/7">
        <title>Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors</title>
        <description>Background:
Evidence documents successful hepatitis C virus (HCV) treatment outcomes for people who inject drugs (PWID) and interest in HCV treatment among this population. Maximising HCV treatment for PWID can be an effective HCV preventative measure. Yet HCV treatment among PWID remains suboptimal. This review seeks to map social factors mediating HCV treatment access.MethodWe undertook a review of the social science and public health literature pertaining to HCV treatment for PWID, with a focus on barriers to treatment access, uptake and completion. Medline and Scopus databases were searched, supplemented by manual and grey literature searches. A two step search was taken, with the first step pertaining to literature on HCV treatment for PWID and the second focusing on social structural factors. In total, 596 references were screened, with 165 articles and reports selected to inform the review.
Results:
Clinical and individual level barriers to HCV treatment among PWID are well evidenced. These include patient and provider concerns regarding co-morbidities, adherence, and side effect management. Social factors affecting treatment access are less well evidenced. In attempting to map these, key barriers fall into the following domains: social stigma, housing, criminalisation, health care systems, and gender. Key facilitating factors to treatment access include: combination intervention approaches encompassing social as well as biomedical interventions, low threshold access to opiate substitution therapy, and integrated delivery of multidisciplinary care.
Conclusion:
Combination intervention approaches need to encompass social interventions in relation to housing, stigma reduction and systemic changes in policy and health care delivery. Future research needs to better delineate social factors affecting treatment access.</description>
        <link>http://www.harmreductionjournal.com/content/10/1/7</link>
                <dc:creator>Magdalena Harris</dc:creator>
                <dc:creator>Tim Rhodes</dc:creator>
                <dc:source>Harm Reduction Journal 2013, null:7</dc:source>
        <dc:date>2013-05-07T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-7517-10-7</dc:identifier>
                                <prism:require>/content/figures/1477-7517-10-7-toc.gif</prism:require>
                <prism:publicationName>Harm Reduction Journal</prism:publicationName>
        <prism:issn>1477-7517</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>7</prism:startingPage>
        <prism:publicationDate>2013-05-07T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.harmreductionjournal.com/content/10/1/6">
        <title>Yet they failed to do so: recommendations based on the experiences of NAOMI research survivors and a call for action</title>
        <description>Background:
This article highlights the experiences of a unique group. In January 2011, Dave Murray organized a group of participants from the North American Opiate Medication Initiative (NAOMI) heroin-assisted treatment clinical trials from 2005 to 2008 in the Downtown Eastside of Vancouver (DTES), B.C., Canada. The NAOMI Patients Association (NPA) is an independent group that currently meets every Saturday in the DTES. Currently, all members of the NPA are former participants in the heroin stream of the clinical trial. The NPA offers support, education, and advocacy to its members.
Methods:
Drawing on brainstorming sessions and focus groups that were conducted in the summer of 2011, this paper highlights the experiences of NPA members in their own words.
Results:
The findings provide a lens to understand how becoming a research subject for the NAOMI trial impacted the lives of NPA members, both positive and negative. The NPA members discuss ethics, consent, recommendations for future HAT programs and studies, and ongoing advocacy.</description>
        <link>http://www.harmreductionjournal.com/content/10/1/6</link>
                <dc:creator>Susan Boyd</dc:creator>
                <dc:source>Harm Reduction Journal 2013, null:6</dc:source>
        <dc:date>2013-04-18T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-7517-10-6</dc:identifier>
                                <prism:require>/content/figures/1477-7517-10-6-toc.gif</prism:require>
                <prism:publicationName>Harm Reduction Journal</prism:publicationName>
        <prism:issn>1477-7517</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>6</prism:startingPage>
        <prism:publicationDate>2013-04-18T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.harmreductionjournal.com/content/10/1/5">
        <title>Between harm reduction, loss and wellness: on the occupational hazards of work</title>
        <description>Those working in the fields of harm reduction, healthcare, and human services must cope with a range of stresses, including post traumatic stress and vicarious trauma. Pain and loss are just a part of the job. So is dealing with premature death as a result of HIV, hypertension, and even overdose. Faced with a range of challenges, some workers in the field even turn to self-medication. For some, it is about pleasure; for others it is about alleviating suffering. In recent years, several leaders in the AIDS and harm reduction fields have died ahead of their time. Some stopped taking their medications; others overdosed. Rather than weakness or pathology, French sociologist Emile Durkheim saw self-destructive behavior as a byproduct of social disorganization and isolation, as a way of contending with a breakdown of social bonds and alienation. There are any number of reasons why such behavior becomes part of work for those involved with battling the dueling epidemics of Hepatitis C, HIV, and related concerns. Forms of stress related to this work include secondary trauma, compassion fatigue, organizational conflict, burnout, complications of direct services, and lack of funding. Faced with day-to- day struggles over poverty, punitive welfare systems, drug use, the war on drugs, high risk behavior, structural violence, and illness, many in the field are left to wonder how to strive for wellness when taking on so much pain. For some, self-injury and self-medication are ways of responding. Building on ethnographic methods, this reflective analysis considers the stories of those who have suffered, as well as a few of the ways those in the field cope with harm and pain. The work considers the moral questions we face when we see our friends and colleagues suffer. It asks how we as practitioners strive to create a culture of wellness and support in the fields of harm reduction, healthcare, and human services. Through a brief review of losses and literature thereof, the essay considers models of harm reduction practice that emphasize health, pleasure and sustainability for practitioners.</description>
        <link>http://www.harmreductionjournal.com/content/10/1/5</link>
                <dc:creator>Benjamin Shepard</dc:creator>
                <dc:source>Harm Reduction Journal 2013, null:5</dc:source>
        <dc:date>2013-04-01T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-7517-10-5</dc:identifier>
                                <prism:require>/content/figures/1477-7517-10-5-toc.gif</prism:require>
                <prism:publicationName>Harm Reduction Journal</prism:publicationName>
        <prism:issn>1477-7517</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>5</prism:startingPage>
        <prism:publicationDate>2013-04-01T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.harmreductionjournal.com/content/10/1/4">
        <title>`On the same level&#191;: facilitators&#191; experiences running a drug user-led safer injecting education campaign</title>
        <description>Background:
Unsafe injection practices play a major role in elevated rates of morbidity and mortality among people who inject drugs (IDU). There is growing interest in the direct involvement of IDU in interventions that seek to address unsafe injecting. This study describes a drug user-led safer injecting education campaign, and explores facilitators&#8217; experiences delivering educational workshops.
Methods:
We conducted semi-structured qualitative interviews with 8 members of the Injection Support (IS) Team who developed and facilitated a series of safer injecting education workshops. Interviews explored facilitator&#8217;s perceptions of the workshops, experiences being a facilitator, and perspectives on the educational campaign. Interviews were transcribed verbatim and a thematic analysis was conducted.
Results:
IS Team facilitators described how the workshop&#8217;s structure and content enabled effective communication of information about safer injecting practices, while targeting the unsafe practices of workshop participants. Facilitators&#8217; identity as IDU enhanced their ability to relate to workshop participants and communicate educational messages in language accessible to workshop participants. Facilitators reported gaining knowledge and skills from their involvement in the campaign, as well as positive feelings about themselves from the realization that they were helping people to protect their health. Overall, facilitators felt that this campaign provided IDU with valuable information, although facilitators also critiqued the campaign and suggested improvements for future efforts.
Conclusions:
This study demonstrates the feasibility of involving IDU in educational initiatives targeting unsafe injecting. Findings illustrate how IDU involvement in prevention activities improves relevance and cultural appropriateness of interventions while providing individual, social, and professional benefits to those IDU delivering education.</description>
        <link>http://www.harmreductionjournal.com/content/10/1/4</link>
                <dc:creator>Cody Callon</dc:creator>
                <dc:creator>Grant Charles</dc:creator>
                <dc:creator>Rick Alexander</dc:creator>
                <dc:creator>Will Small</dc:creator>
                <dc:creator>Thomas Kerr</dc:creator>
                <dc:source>Harm Reduction Journal 2013, null:4</dc:source>
        <dc:date>2013-03-06T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-7517-10-4</dc:identifier>
                                <prism:require>/content/figures/1477-7517-10-4-toc.gif</prism:require>
                <prism:publicationName>Harm Reduction Journal</prism:publicationName>
        <prism:issn>1477-7517</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>4</prism:startingPage>
        <prism:publicationDate>2013-03-06T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.harmreductionjournal.com/content/10/1/3">
        <title>Predictors of retention in community-based methadone maintenance treatment program in Pearl River Delta, China</title>
        <description>Background:
The aims were to identify predictors of treatment retention in methadone maintenance treatment (MMT) clinics in Pearl River Delta, China.
Methods:
Retrospective longitudinal study. Participants: 6 MMT clinics in rural and urban area were selected. Statistical analysis: Stratified random sampling was employed, and the data were analyzed using Kaplan-Meier survival curves and life table method. Protective or risk factors were explored using Cox&#8217;s proportional hazards model. Independent variables were enrolled in univariate analysis and among which significant variables were analyzed by multivariate analysis.
Results:
A total of 2728 patients were enrolled. The median of the retention duration was 13.63 months, and the cumulative retention rates at 1,2,3 years were 53.0%, 35.0%, 20.0%, respectively. Multivariate Cox analysis showed: age, relationship with family, live on support from family or friends, income, considering treatment cost suitable, considering treatment open time suitable, addiction severity (daily expense for drug), communication with former drug taking peer, living in rural area, daily treatment dosage, sharing needles, re-admission and history of being arrested were predictors for MMT retention.
Conclusions:
MMT retention rate in Guangdong was low and treatment skills and quality should be improved. Meanwhile, participation of family and society should be encouraged.</description>
        <link>http://www.harmreductionjournal.com/content/10/1/3</link>
                <dc:creator>Fang Yang</dc:creator>
                <dc:creator>Peng Lin</dc:creator>
                <dc:creator>Yan Li</dc:creator>
                <dc:creator>Qun He</dc:creator>
                <dc:creator>Qisui Long</dc:creator>
                <dc:creator>Xiaobing Fu</dc:creator>
                <dc:creator>Yulan Luo</dc:creator>
                <dc:source>Harm Reduction Journal 2013, null:3</dc:source>
        <dc:date>2013-03-06T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-7517-10-3</dc:identifier>
                                <prism:require>/content/figures/1477-7517-10-3-toc.gif</prism:require>
                <prism:publicationName>Harm Reduction Journal</prism:publicationName>
        <prism:issn>1477-7517</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>3</prism:startingPage>
        <prism:publicationDate>2013-03-06T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.harmreductionjournal.com/content/10/1/2">
        <title>Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study</title>
        <description>Background:
Despite its increasing prevalence and acceptance among the general public, cannabis use continues to be viewed as an aberrant activity in many contexts. However, little is known about how stigma associated with cannabis use affects individuals who use cannabis for therapeutic purposes (CTP) and what strategies these individuals employ to manage associated stigma. The aim of this Canadian study was to describe users&#8217; perceptions of and responses to the stigma attached to using CTP.
Methods:
Twenty-three individuals who were using CTP for a range of health problems took part in semi-structured interviews. Transcribed data were analyzed using an inductive approach and comparative strategies to explore participants&#8217; perceptions of CTP and identify themes.
Results:
Participant experiences of stigma were related to negative views of cannabis as a recreational drug, the current criminal sanctions associated with cannabis use, and using cannabis in the context of stigmatizing vulnerability (related to existing illness and disability). Strategies for managing the resulting stigma of using CTP included: keeping CTP &#8216;undercover&#8217;; educating those who did not approve of or understand CTP use; and using cannabis responsibly.
Conclusions:
Understanding how individuals perceive and respond to stigma can inform the development of strategies aimed at reducing stigma associated with the use of CTP and thereby address barriers faced by those using this medicine.</description>
        <link>http://www.harmreductionjournal.com/content/10/1/2</link>
                <dc:creator>Joan Bottorff</dc:creator>
                <dc:creator>Laura Bissell</dc:creator>
                <dc:creator>Lynda Balneaves</dc:creator>
                <dc:creator>John Oliffe</dc:creator>
                <dc:creator>N Capler</dc:creator>
                <dc:creator>Jane Buxton</dc:creator>
                <dc:source>Harm Reduction Journal 2013, null:2</dc:source>
        <dc:date>2013-02-16T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-7517-10-2</dc:identifier>
                                <prism:require>/content/figures/1477-7517-10-2-toc.gif</prism:require>
                <prism:publicationName>Harm Reduction Journal</prism:publicationName>
        <prism:issn>1477-7517</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>2</prism:startingPage>
        <prism:publicationDate>2013-02-16T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.harmreductionjournal.com/content/10/1/1">
        <title>Should North America&amp;#8217;s first and only supervised injection facility (InSite) be expanded in British Columbia, Canada?</title>
        <description>Background:
This article reports qualitative findings from a sample of 31 purposively chosen injection drug users (IDUs) from Vancouver, Surrey and Victoria, British Columbia interviewed to examine the context of safe injection site in transforming their lives. Further, the purpose is to determine whether the first and only Supervised injection facility (SIF) in North America, InSite, needs to be expanded to other cities.
Methods:
Semi-structured qualitative interviews were conducted in a classical anthropological strategy of conversational format as drug users were actively involved in their routine activities. Purposive sampling combined with snowball sampling techniques was employed to recruit the participants. Audio recorded interviews were transcribed verbatim and analyzed thematically using NVivo 9 software.
Results:
Attending InSite has numerous positive effects on the lives of IDUs including: saving lives, reducing HIV and HCV risk behavior, decreasing injection in public, reducing public syringe disposal, reducing use of various medical resources and increasing access to nursing and other primary health services.
Conclusions:
There is an urgent need to expand the current facility to cities where injection drug use is prevalent to reduce overdose deaths, reduce needle sharing, reduce hospital emergency care, and increase safety. In addition, InSite&#8217;s positive changes have contributed to a cultural transformation in drug use within the Downtown Eastside and neighboring communities.</description>
        <link>http://www.harmreductionjournal.com/content/10/1/1</link>
                <dc:creator>Ehsan Jozaghi</dc:creator>
                <dc:creator>Martin Andresen</dc:creator>
                <dc:source>Harm Reduction Journal 2013, null:1</dc:source>
        <dc:date>2013-02-16T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-7517-10-1</dc:identifier>
                                <prism:require>/content/figures/1477-7517-10-1-toc.gif</prism:require>
                <prism:publicationName>Harm Reduction Journal</prism:publicationName>
        <prism:issn>1477-7517</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>1</prism:startingPage>
        <prism:publicationDate>2013-02-16T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.harmreductionjournal.com/content/9/1/40">
        <title>Understanding the association between injecting and sexual risk behaviors of injecting drug users in Manipur and Nagaland, India</title>
        <description>Background:
In India, as in rest of the world, HIV prevention programs have focused on HIV transmission through unsafe injecting practices with less attention on sexual risk behaviors among injecting drug users (IDUs). This study examines the sexual risk taking behaviors of IDUs associated with their pattern of drug use in India.
Methods:
Data were obtained from the behavioral tracking survey conducted in 2009 among 1712 IDUs in two districts each of Manipur and Nagaland states in Northeastern part of India. Sexual risk behaviors among IDUs were assessed in terms of multiple sex partners, sex with a paid female partner in the last 12&#8201;months and inconsistent condom use with any female partner.
Results:
More than one-fourth (27%) in Manipur and almost one in two (47%) IDUs reported having had sex with two or more female partners in the past 12&#8201;months. In Manipur where heroin is commonly used, the odds of having multiple sex partners were higher among non-heroin users than heroin users (42% vs. 23%, Adjusted Odds Ratio (AOR): 1.7, 95% Confidence Interval (CI): 1.1-2.6) and who shared needles/syringes in the last one month than who did not share (46% vs. 26%, AOR: 2.2, CI: 1.2-4.0). In Nagaland, where Spasmoproxyvon (SP, a synthetic opioid analgesic that contains dextropropoxyphene, dicyclomine hydrochloride and paracetamol) is most common, regular injectors as compared to occasional injectors were more likely to report multiple sex partners (67% vs. 42%, AOR: 2.7, CI: 1.8-4.1) and sex with paid partners (13% vs. 3%, AOR: 6.0, CI: 3.0-12.1). Sharing of needles/syringes was positively associated with multiple sex partners (51% vs. 44%, AOR: 1.6, CI: 1.2-2.2), and inconsistent condom use (93% vs. 80%, AOR: 3.0, CI: 1.8-5.1).
Conclusions:
IDUs with unsafe injecting practices also engage in risky sexual practices magnifying the risk of HIV infection. There is a need to focus on prevention of sexual transmission among high-risk IDUs, particularly in areas where Spasmoproxyvon is commonly used.</description>
        <link>http://www.harmreductionjournal.com/content/9/1/40</link>
                <dc:creator>Khrieketou Suohu</dc:creator>
                <dc:creator>Chumben Humtsoe</dc:creator>
                <dc:creator>Niranjan Saggurti</dc:creator>
                <dc:creator>Shrutika Sabarwal</dc:creator>
                <dc:creator>Bidhubhusan Mahapatra</dc:creator>
                <dc:creator>Michelle Kermode</dc:creator>
                <dc:source>Harm Reduction Journal 2012, null:40</dc:source>
        <dc:date>2012-12-18T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-7517-9-40</dc:identifier>
                                <prism:require>/content/figures/1477-7517-9-40-toc.gif</prism:require>
                <prism:publicationName>Harm Reduction Journal</prism:publicationName>
        <prism:issn>1477-7517</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>40</prism:startingPage>
        <prism:publicationDate>2012-12-18T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.harmreductionjournal.com/content/9/1/39">
        <title>Determinants of cigarette smoking among school adolescents in eastern Ethiopia: a cross-sectional study</title>
        <description>Background:
The World Health Organization (WHO) attributes more than 4 million deaths a year to tobacco, and it is expected that this figure will rise to 10 million deaths a year by 2020. Moreover, it is now a growing public health problem in the developing world.ObjectiveTo assess the prevalence of cigarette use and its determinant factors among high school students in eastern Ethiopia.
Methods:
A cross-sectional study was conducted using structured self-administered questionnaires among 1,721 school adolescents in Harar town, eastern Ethiopia. Univariate and multivariate logistic regression analyses were performed to examine associations.
Results:
The analysis revealed that prevalence of ever cigarette smoking was 12.2% (95% CI 10.8% - 13.9%). Reasons mentioned for smoking cigarettes were for enjoyment (113, 52.8%), for trial (92, 42.9%), and for other reasons (9, 4.3%). The main predictors of cigarette smoking were sex (OR 4.32; 95% CI 2.59-7.22), age (OR 1.20; 95% CI 1.05-1.38) and having friends who smoke (OR 8.14; 95% CI 5.19-12.70). Living with people who smoke cigarettes was not significantly associated with smoking among adolescents (OR 1.25; 95% CI 0.81-1.92).
Conclusion:
This study concluded that high proportion of school adolescents in Harar town smoked cigarettes. Sex, age and peer influence were identified as important determinants of smoking. There is a need for early cost-effective interventions and education campaigns that target secondary school students.</description>
        <link>http://www.harmreductionjournal.com/content/9/1/39</link>
                <dc:creator>Ayalu Reda</dc:creator>
                <dc:creator>Asmamaw Moges</dc:creator>
                <dc:creator>Berhanu Yazew</dc:creator>
                <dc:creator>Sibhatu Biadgilign</dc:creator>
                <dc:source>Harm Reduction Journal 2012, null:39</dc:source>
        <dc:date>2012-12-10T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-7517-9-39</dc:identifier>
                                <prism:require>/content/figures/1477-7517-9-39-toc.gif</prism:require>
                <prism:publicationName>Harm Reduction Journal</prism:publicationName>
        <prism:issn>1477-7517</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>39</prism:startingPage>
        <prism:publicationDate>2012-12-10T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
